Cargando…

More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis

Allergic bronchial asthma is a chronic disease of the airways that is characterized by symptoms like respiratory distress, chest tightness, wheezing, productive cough, and acute episodes of broncho-obstruction. This symptom-complex arises on the basis of chronic allergic inflammation of the airway w...

Descripción completa

Detalles Bibliográficos
Autores principales: Frey, Andreas, Lunding, Lars P., Ehlers, Johanna C., Weckmann, Markus, Zissler, Ulrich M., Wegmann, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198799/
https://www.ncbi.nlm.nih.gov/pubmed/32411147
http://dx.doi.org/10.3389/fimmu.2020.00761
_version_ 1783529060084744192
author Frey, Andreas
Lunding, Lars P.
Ehlers, Johanna C.
Weckmann, Markus
Zissler, Ulrich M.
Wegmann, Michael
author_facet Frey, Andreas
Lunding, Lars P.
Ehlers, Johanna C.
Weckmann, Markus
Zissler, Ulrich M.
Wegmann, Michael
author_sort Frey, Andreas
collection PubMed
description Allergic bronchial asthma is a chronic disease of the airways that is characterized by symptoms like respiratory distress, chest tightness, wheezing, productive cough, and acute episodes of broncho-obstruction. This symptom-complex arises on the basis of chronic allergic inflammation of the airway wall. Consequently, the airway epithelium is central to the pathogenesis of this disease, because its multiple abilities directly have an impact on the inflammatory response and thus the formation of the disease. In turn, its structure and functions are markedly impaired by the inflammation. Hence, the airway epithelium represents a sealed, self-cleaning barrier, that prohibits penetration of inhaled allergens, pathogens, and other noxious agents into the body. This barrier is covered with mucus that further contains antimicrobial peptides and antibodies that are either produced or specifically transported by the airway epithelium in order to trap these particles and to remove them from the body by a process called mucociliary clearance. Once this first line of defense of the lung is overcome, airway epithelial cells are the first cells to get in contact with pathogens, to be damaged or infected. Therefore, these cells release a plethora of chemokines and cytokines that not only induce an acute inflammatory reaction but also have an impact on the alignment of the following immune reaction. In case of asthma, all these functions are impaired by the already existing allergic immune response that per se weakens the barrier integrity and self-cleaning abilities of the airway epithelium making it more vulnerable to penetration of allergens as well as of infection by bacteria and viruses. Recent studies indicate that the history of allergy- and pathogen-derived insults can leave some kind of memory in these cells that can be described as imprinting or trained immunity. Thus, the airway epithelium is in the center of processes that lead to formation, progression and acute exacerbation of asthma.
format Online
Article
Text
id pubmed-7198799
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71987992020-05-14 More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis Frey, Andreas Lunding, Lars P. Ehlers, Johanna C. Weckmann, Markus Zissler, Ulrich M. Wegmann, Michael Front Immunol Immunology Allergic bronchial asthma is a chronic disease of the airways that is characterized by symptoms like respiratory distress, chest tightness, wheezing, productive cough, and acute episodes of broncho-obstruction. This symptom-complex arises on the basis of chronic allergic inflammation of the airway wall. Consequently, the airway epithelium is central to the pathogenesis of this disease, because its multiple abilities directly have an impact on the inflammatory response and thus the formation of the disease. In turn, its structure and functions are markedly impaired by the inflammation. Hence, the airway epithelium represents a sealed, self-cleaning barrier, that prohibits penetration of inhaled allergens, pathogens, and other noxious agents into the body. This barrier is covered with mucus that further contains antimicrobial peptides and antibodies that are either produced or specifically transported by the airway epithelium in order to trap these particles and to remove them from the body by a process called mucociliary clearance. Once this first line of defense of the lung is overcome, airway epithelial cells are the first cells to get in contact with pathogens, to be damaged or infected. Therefore, these cells release a plethora of chemokines and cytokines that not only induce an acute inflammatory reaction but also have an impact on the alignment of the following immune reaction. In case of asthma, all these functions are impaired by the already existing allergic immune response that per se weakens the barrier integrity and self-cleaning abilities of the airway epithelium making it more vulnerable to penetration of allergens as well as of infection by bacteria and viruses. Recent studies indicate that the history of allergy- and pathogen-derived insults can leave some kind of memory in these cells that can be described as imprinting or trained immunity. Thus, the airway epithelium is in the center of processes that lead to formation, progression and acute exacerbation of asthma. Frontiers Media S.A. 2020-04-28 /pmc/articles/PMC7198799/ /pubmed/32411147 http://dx.doi.org/10.3389/fimmu.2020.00761 Text en Copyright © 2020 Frey, Lunding, Ehlers, Weckmann, Zissler and Wegmann. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Frey, Andreas
Lunding, Lars P.
Ehlers, Johanna C.
Weckmann, Markus
Zissler, Ulrich M.
Wegmann, Michael
More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis
title More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis
title_full More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis
title_fullStr More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis
title_full_unstemmed More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis
title_short More Than Just a Barrier: The Immune Functions of the Airway Epithelium in Asthma Pathogenesis
title_sort more than just a barrier: the immune functions of the airway epithelium in asthma pathogenesis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7198799/
https://www.ncbi.nlm.nih.gov/pubmed/32411147
http://dx.doi.org/10.3389/fimmu.2020.00761
work_keys_str_mv AT freyandreas morethanjustabarriertheimmunefunctionsoftheairwayepitheliuminasthmapathogenesis
AT lundinglarsp morethanjustabarriertheimmunefunctionsoftheairwayepitheliuminasthmapathogenesis
AT ehlersjohannac morethanjustabarriertheimmunefunctionsoftheairwayepitheliuminasthmapathogenesis
AT weckmannmarkus morethanjustabarriertheimmunefunctionsoftheairwayepitheliuminasthmapathogenesis
AT zisslerulrichm morethanjustabarriertheimmunefunctionsoftheairwayepitheliuminasthmapathogenesis
AT wegmannmichael morethanjustabarriertheimmunefunctionsoftheairwayepitheliuminasthmapathogenesis